Turn Therapeutics Inc.
TTRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$293.11M
Close$
$0.36
96.2% downside
Current Fair Value
96.2% downsideOvervalued by 96.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $293.11 Million |
|---|---|
| Enterprise Value | $288.95 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 2.02 |
| Outstanding Shares | 29,788,040 |
Return
| Return on Equity | -1229.58% |
|---|---|
| Return on Assets | -49.80% |
| Return on Invested Capital | -85.17% |
Valuation & Multiples
| P/E Ratio | -33.77 |
|---|---|
| PEG | -9.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -41.39 |
| Enterprise Value to Net Income | -35 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 8.91 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.57%▼ 0.02% |
|---|---|
| Total Invested | $1.48M▼ 19.50% |
| Investors Holding | 20▼ 2.00% |
ESG Score
No data
About Turn Therapeutics Inc.
2 employees
CEO: Bradley E. Burnam Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails ...